Organisation paid for research Program year 2025 Source: CMS Open Payments

Accellacare Clinical Research

Neither a doctor nor a teaching hospital

Research payments

$64,747

7 payments

Through program year 2025, Accellacare Clinical Research is reported as receiving $64,747 in research payments, across 7 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$16,122	2
2024	Research	$33,002	3
2023	Research	$15,624	2

Breakdown

Who paid Research payments · program years 2023–2025

Celgene Corporation $35,260 5 payments
Novo Nordisk AS $16,432 1 payment
AstraZeneca Pharmaceuticals LP $13,055 1 payment

Studies the money was for Research payments · program years 2023–2025

A Multicenter, Longitudinal, Open-Label, Single-Arm Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated with Ozanimod (RPC-1063) $35,260 5 payments
Nn9838-4608 $16,432 1 payment
a phase 3,global,randomized,modified double blind,placebo controlled,study to evaluate the efficacy,immunogenicity,and safety of IVX A12,a respiratory syncytial virus RSV and human metapneumovirus hMPV virus like particle VLP vaccine in adults 60 years of age and older $13,055 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.